LSA
VRTX icon

L & S Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

L & S Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,146
Closed -$1.4M – 365
2025
Q2 		$1.4M Sell
3,146
-158
-5% -$72.8K 0.14% 151
2025
Q1 		$1.6M Buy
3,304
+493
+18% +$230K 0.2% 131
2024
Q4 		$1.13M Sell
2,811
-406
-13% -$188K 0.12% 169
2024
Q3 		$1.5M Sell
3,217
-265
-8% -$127K 0.16% 153
2024
Q2 		$1.63M Buy
3,482
+173
+5% +$75.1K 0.19% 143
2024
Q1 		$1.38M Buy
3,309
+122
+4% +$51.6K 0.16% 161
2023
Q4 		$1.3M Sell
3,187
-1,091
-26% -$403K 0.16% 148
2023
Q3 		$1.49M Buy
4,278
+947
+28% +$331K 0.21% 123
2023
Q2 		$1.17M Buy
3,331
+772
+30% +$260K 0.16% 138
2023
Q1 		$806K Sell
2,559
-614
-19% -$184K 0.11% 174
2022
Q4 		$916K Buy
+3,173
New +$967K 0.17% 137
2020
Q4 		– Sell
-4,535
Closed -$1.23M – 368
2020
Q3 		$1.23M Buy
4,535
+586
+15% +$162K 0.17% 171
2020
Q2 		$1.15M Sell
3,949
-232
-6% -$62.9K 0.17% 151
2020
Q1 		$995K Buy
4,181
+1,381
+49% +$317K 0.19% 120
2019
Q4 		$613K Buy
+2,800
New +$567K 0.08% 194

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

L & S Advisors's VRTX Position: Q3 2025 in Review

L & S Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 3,146 shares — an estimated $1.4M sold.

L & S Advisors first reported a position in VRTX in Q4 2019 and held it in 15 quarters. The position peaked at $1.63M in Q2 2024. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • L & S Advisors reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • L & S Advisors sold 3,146 Vertex Pharmaceuticals shares in Q3 2025, an estimated $1.4M.
  • L & S Advisors first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 15 quarters.
  • L & S Advisors's Vertex Pharmaceuticals position peaked at $1.63M in Q2 2024.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on L & S Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.